MGNX - MacroGenics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 51.38B
Enterprise value 31.27B
Trailing P/E N/A
Forward P/E 1-14.98
PEG Ratio (5 yr expected) 10.03
Price/sales (ttm)20.19
Price/book (mrq)7.22
Enterprise value/revenue 318.68
Enterprise value/EBITDA 6-7.76

Trading information

Stock price history

Beta (5Y monthly) 2.82
52-week change 390.22%
S&P500 52-week change 37.73%
52-week high 332.18
52-week low 34.04
50-day moving average 325.41
200-day moving average 314.41

Share statistics

Avg vol (3-month) 33.27M
Avg vol (10-day) 3658.14k
Shares outstanding 549.13M
Float 47.48M
% held by insiders 17.42%
% held by institutions 194.18%
Shares short (29 Jun 2020) 44.67M
Short ratio (29 Jun 2020) 43.65
Short % of float (29 Jun 2020) 411.21%
Short % of shares outstanding (29 Jun 2020) 49.50%
Shares short (prior month 28 May 2020) 44.33M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin -222.14%
Operating margin (ttm)-256.59%

Management effectiveness

Return on assets (ttm)-32.17%
Return on equity (ttm)-59.28%

Income statement

Revenue (ttm)68.21M
Revenue per share (ttm)1.39
Quarterly revenue growth (yoy)41.60%
Gross profit (ttm)-131.12M
EBITDA -164.26M
Net income avi to common (ttm)-151.52M
Diluted EPS (ttm)-3.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)170.85M
Total cash per share (mrq)3.48
Total debt (mrq)29.7M
Total debt/equity (mrq)15.59
Current ratio (mrq)4.93
Book value per share (mrq)3.88

Cash flow statement

Operating cash flow (ttm)-148.41M
Levered free cash flow (ttm)-103.55M